ABSTRACT The effect of prednisolone on the elimination kinetics of theophylline was studied in a group of nine patients with chronic airflow obstruction. Volume of distribution, plasma half life, and clearance after a single intravenous dose of aminophylline (5-6 mg/kg) were unchanged by prednisolone treatment (20 mg daily for three weeks). The metabolism of an intravenous bolus of theophylline is not influenced by oral prednisolone.
Theophylline is widely used as a bronchodilator for patients with airways obstruction. Its efficacy has been shown to relate directly to serum concentrations,1 while toxic effects are commonly observed when the upper limit of the therapeutic range (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) ig/ml) is exceeded.2 Clearly, any factor that influences the pharmacokinetics of theophylline, thereby altering serum concentrations, must be carefully controlled if the maximum clinical effectiveness of the drug is to be obtained without the risk of dangerous toxicity. Studies of theophylline elimination in normal subjects have shown appreciable variations between individuals34 and many factors that alter the plasma clearance of the drug have been identified. Liver disease,5 congestive heart failure,' severe airways obstruction,7 respiratory infection,7 8 and drugs (including erythromycin9 and cimetidinei0) are known to decrease theophylline clearance. Cigarette smoking,11 certain diets,12 13 and drugs such as phenobarbitone14 that induce hepatic microsomal enzymes increase the elimination of theophylline.
Many patients prescribed theophylline preparations for airways obstruction also take inhaled or systemic corticosteroids. Surprisingly little is known of the effect of the latter on theophylline pharmacokinetics. In 1979 Buchanan and colleagues15 briefly reported the development of theophylline toxicity in Address for reprint requests: Dr J Gaddie, Peel Hospital, Galashiels TDI 3LQ. Accepted 10 October 1986 three patients given large doses of hydrocortisone for severe acute asthma. By contrast, a recent study16 in healthy volunteers showed a significant increase in theophylline clearance during an infusion of corticosteroid. We have studied the effect of prednisolone on theophylline pharmacokinetics after an intravenous injection of aminophylline in nine patients with chronic airflow obstruction.
Methods
We studied nine patients (five of them men), aged 47-71 (mean 61) years, with chronic airflow obstruction. Five were ex-smokers, two current smokers, and two non-smokers. Five patients had positive skin test responses to common allergens and two had blood eosinophilia. Patients were only inhaling drugs-# agonists in nine cases, ipratropium in three, sodium cromoglycate in two, and steroids in five. All had shown spontaneous variability in FEV1 of at least 20% at two previous clinic attendances and were considered suitable for a "trial" of prednisolone treatment. None had significant cardiac disease; one man had slightly abnormal results in liver function tests. No one was taking medications known to interact with theophylline. None of the five patients inhaling beclomethasone diproprionate received more than 400 ig per day.
Theophylline pharmacokinetics were studied on two separate occasions-before treatment with prednisolone (study 1) and during treatment with prednisolone (study 2). Beverages containing xanthine derivatives were not consumed for 12 hours before each study or at any time during the investigation. 196 Venous blood was taken for estimation of plasma urea and electrolyte concentrations. Liver function (serum bilirubin concentration and alkaline phosphatase, aspartate transaminase, and y glutamyl transferase activities) and plasma theophylline concentration were determined before the start of the study.
Aminophylline 5-6 mg/kg (equivalent to 4-43 mg/kg of theophylline) in 60ml normal saline was then infused intravenously over 15 minutes. Venous blood samples were drawn from the contralateral arm into heparinised tubes for determining plasma theophylline concentrations at 15 minutes (end of infusion): at 30, 45, 60, 90, 120, 150, and 180 minutes; and then hourly until eight hours after the start of the infusion.
The FEV1 and forced vital capacity (FVC) were measured with a Vitalograph spirometer (best of three attempts) after the patient had had a 15 minute rest on arrival at the hospital and then 15, 30, and 60 minutes after the infusion. The pulse rate, measured by palpation of the radial artery, was also recorded at these times. Any side effects of the treatment were noted.
After the study the patients started treatment with enteric coated prednisolone tablets 20mg daily for three weeks. The study was repeated at the end of this period while the patient was still receiving prednisolone. To check drug compliance, a known excess quantity of tablets was prescribed and the patient was asked to return all spare tablets at the end of the study. The paired Student's t test was used for statistical analysis.
All subjects gave informed consent to the study, which was approved by the ethical committee of the Borders Health Board.
Results
The elimination of theophylline during each eight hour study period is shown in the figure. The volume of distribution, plasma half life, and clearance did not differ significantly between study I and study 2 ( 5 6 8
Mean plasma theophylline concentration against time curves for each study.
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